
|Articles|October 1, 2015
- Applied Clinical Trials-10-01-2015
- Volume 24
- Issue 10
Applied Clinical Trials Digital Edition - October/November 2015
Trial Design: Gene Transfer: Key Challenges Therapy Masking Assessment Safety Reporting: Death Waivers Fall Short Subject Engagement: Phase I Satisfaction Scores Also in this issue: Informed Consent Changes in Works Europe's Embrace of New Science Alzheimer's and Patient Safety
Advertisement
Articles in this issue
almost 11 years ago
Top Investigator Lays out Strategy for Avoiding Conflictsalmost 11 years ago
Changes Ahead for Informed Consent, IRBs, Transparencyalmost 11 years ago
Europe: At Last, the Hunt is On for Trials That Fit Sciencealmost 11 years ago
Developing New Alzheimer’s Drugs With a Focus on Patient Safetyalmost 11 years ago
Inclusion/Exclusion Criteria Show Minimal Risealmost 11 years ago
A New Look at the Arsenal of Tech Solutionsalmost 11 years ago
Human Gene Transfer Studies: What Clinicians Should Knowalmost 11 years ago
Death Waivers an Incomplete Picture of Drug Safetyalmost 11 years ago
Evaluating the Effects of Therapy Maskingalmost 11 years ago
Satisfaction of Healthy Subjects in Phase I TrialsAdvertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
$500,000 Lost a Day: The Economics of Clinical Trial Execution Is Pharma's Expensive Secret
2
ACT Brief: Real-Time Monitoring Through Quick Wins, Consumer Wearable Validation Requirements, and Replimune RP1 Efficacy Data Advancement
3
Bridging Data Gaps: Curating Real-World Data for Oncology Research
4
Validity, Reliability, and Regulatory Considerations for Consumer Devices in Clinical Research Data Collection
5



